Bicara Therapeutics BCAX
NASDAQ BCAX
$18.20 -0.41 (-2.20%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bicara Therapeutics (BCAX) Price to Book (2024 - 2026)

Updated

Bicara Therapeutics' (BCAX) Price to Book came in at 4.18 for Q2 2026, up 258.6% from 1.16 a year earlier and up 64.6% from the prior quarter.

Analysis

Bicara Therapeutics (BCAX) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Bicara Therapeutics' Price to Book stood at 2.37, up 298.7% from FY2024.

  • In prior years, Bicara Therapeutics' Price to Book was 0.60 in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Price to Book in data going back to Q3 2024.
  • On a year-over-year basis, Price to Book has increased in each of the last four quarters, with growth averaging 228.5% over the last four quarters.
  • According to Business Quant data, Price to Book for the three prior quarters was 2.54 (Q1 2026), 2.37 (Q4 2025) and 2.14 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bicara Therapeutics 1.23 Bn 1.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.18
Mar 31, 2026 2.54
Dec 31, 2025 2.37
Sep 30, 2025 2.14
Jun 30, 2025 1.16
Mar 31, 2025 1.55
Dec 31, 2024 0.60
Sep 30, 2024 0.54
API Access

Bicara Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=BCAX&period=max&api_key=YOUR_API_KEY